Tara Maddala, Ph.D. is the Head of Biostatistics and Data Management at GRAIL. GRAIL’s mission is to detect cancer early—when it can be cured—by combining the techniques of modern data-science with the value of cfNA signals from high-intensity sequencing of unprecedented breadth and depth. Tara’s team collaborates with clinicians, scientists, and information technologists to design and execute on one of the largest clinical trial programs ever pursued in genomic medicine. Before GRAIL, Tara led the Clinical Biostatistics team at Genomic Health responsible for design and analysis of large-scale oncology biomarker studies that resulted in algorithm-based, clinically-actionable commercial diagnostics. Before Genomic Health, Tara was Director of Biostatistics at Clinimetrics, where she supported the development and approval of several therapeutics for small-to-medium biotechnology companies. She holds a bachelor’s degree in Industrial and Systems Engineering from the University of Florida, a master's degree in Health Systems Engineering from Georgia Tech, and a Ph.D. in Biostatistics from The University of Texas.
Expanding the Possibilities of Personalized Medicine Through Collaborative Data Collection, Sharing, and Analysis
2:05 PM - 2:55 PM